Maravai LifeSciences Holdings, Inc. Deferred Foreign Income Tax Expense (Benefit)
Maravai LifeSciences Holdings, Inc. (MRVI) reported Deferred Foreign Income Tax Expense (Benefit) of -$20.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-26
- Maravai LifeSciences Holdings, Inc. deferred foreign income tax expense (benefit) for fiscal 2025 was -$20.00K, a 281.82% decline from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was $11.00K.
- Maravai LifeSciences Holdings, Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was $0.00.
- Maravai LifeSciences Holdings, Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$20.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | $11.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2022-12-31 | $0.00 10-K · filed 2025-03-18 |